Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Psychology
Impact Of Sociodemographic Status And Sex On Chronic Rhinosinusitis And Olfaction In People With Cystic Fibrosis., Ethan J. Han, Christine M. Liu, Jakob L. Fischer, Jess C. Mace, Karolin Markarian, Jeremiah A. Alt, Todd E. Bodner, Naweed I. Chowdhury, Patricia H. Eshaghian, Yuqing A. Gao, Multiple Additional Authors
Impact Of Sociodemographic Status And Sex On Chronic Rhinosinusitis And Olfaction In People With Cystic Fibrosis., Ethan J. Han, Christine M. Liu, Jakob L. Fischer, Jess C. Mace, Karolin Markarian, Jeremiah A. Alt, Todd E. Bodner, Naweed I. Chowdhury, Patricia H. Eshaghian, Yuqing A. Gao, Multiple Additional Authors
Psychology Faculty Publications and Presentations
Sociodemographic status (SDS) including race/ethnicity and socioeconomic status as approximated by education, income, and insurance status impact pulmonary disease in people with cystic fibrosis (PwCF). The relationship between SDS and chronic rhinosinusitis (CRS) remains understudied.
Predictors Of Sinonasal Improvement After Highly Effective Modulator Therapy In Adults With Cystic Fibrosis, Daniel M. Beswick, Christine M. Liu, Jonathan B. Overdevest, Anna Zemke, Aastha Khatiwada, David A. Gudis, Jessa E. Miller, Adam Kimple, Jeremy P. Tervo, Todd E. Bodner, Multiple Additional Authors
Predictors Of Sinonasal Improvement After Highly Effective Modulator Therapy In Adults With Cystic Fibrosis, Daniel M. Beswick, Christine M. Liu, Jonathan B. Overdevest, Anna Zemke, Aastha Khatiwada, David A. Gudis, Jessa E. Miller, Adam Kimple, Jeremy P. Tervo, Todd E. Bodner, Multiple Additional Authors
Psychology Faculty Publications and Presentations
The 22-question SinoNasal Outcome Test (SNOT-22) assesses chronic rhinosinusitis (CRS) severity. We aimed to identify predictors of SNOT-22 score improvement following highly effective modulator therapy (HEMT) initiation and to corroborate the SNOT-22 minimal clinically important difference (MCID) in adults with cystic fibrosis (CF).